Search Results - "Sonoda, Tomoaki"

Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplant Diagnosed Using Ultrathin Bronchoscopy by Sato, Masayuki, Waseda, Yuko, Sonoda, Tomoaki, Tanizawa, Akihiko, Itoh, Harumi, Kobayashi, Motohiro, Takemura, Tamiko, Ishizuka, Tamotsu

“…Sato et al discuss the case of a 20-year-old woman presented with dyspnea and wheezing. The patient had previously undergone hematopoietic stem cell transplant…”
Get full text

A Case of Refractory Pemphigus Herpetiformis with Positive Anti-Desmoglein 1 Antibody: Case Report and Literature Review to Revisit the Disease Characteristics of 167 Cases by Higashida, Shintaro, Nishimura, Kentarou, Muneishi, Yoriko, Sonoda, Tomoaki, Anzai, Masaki, Kawasaki, Takeo, Koga, Hiroshi, Ishii, Norito, Oyama, Noritaka, Hasegawa, Minoru

Get full text

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients by Kitazono, Satoru, Sakai, Kazuko, Yanagitani, Noriko, Ariyasu, Ryo, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Uchibori, Ken, Horiike, Atsushi, Nishio, Kazuto, Nishio, Makoto

“…Most patients with epidermal growth factor receptor (EGFR) mutation‐positive non‐small cell lung cancer (NSCLC) will inevitably develop acquired resistance…”
Get full text

Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study by Nakashima, Koki, Umeda, Yukihiro, Demura, Yoshiki, Takeda, Toshihiro, Tada, Toshihiko, Sato, Masayuki, Jikuya, Norihiro, Kurokawa, Kosuke, Sonoda, Tomoaki, Yamaguchi, Makiko, Mitsui, Miho, Oi, Masahiro, Chikazawa, Ryo, Waseda, Yuko, Anzai, Masaki, Akai, Masaya, Ishizuka, Tamotsu

“…Although transbronchial diagnostic procedures are sometimes difficult to perform because of the patient's respiratory or general conditions, endoscopic…”
Get full text

Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody by Saiki, Masafumi, Yoshizawa, Takahiro, Dotsu, Yosuke, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Nishio, Makoto

“…•Serum ADA increased from baseline in the patients who response for anti-PD-1 therapy.•Serum ADA decreased from baseline regardless of response in the…”
Get full text

Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene by Saiki, Masafumi, Ohyanagi, Fumiyoshi, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

“…Inflammatory myofibroblastic tumor (IMT) is a neoplasm characterized by the proliferaton of myofibroblasts with the infiltration of inflammatory cells. There…”
Get full text

Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial by Sonoda, Tomoaki, Umeda, Yukihiro, Demura, Yoshiki, Tada, Toshihiko, Nakashima, Koki, Anzai, Masaki, Yamaguchi, Makiko, Shimada, Akikazu, Ohi, Masahiro, Honjo, Chisato, Waseda, Yuko, Akai, Masaya, Ishizuka, Tamotsu

“…Background Whether immunotherapy improves the efficacy or worsens adverse events of subsequent chemotherapy remains unclear. We performed a Phase 2 study to…”
Get full text

Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer by Koyama, Junji, Horiike, Atsushi, Yoshizawa, Takahiro, Dotsu, Yosuke, Ariyasu, Ryo, Saiki, Masafumi, Sonoda, Tomoaki, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

“…Recent studies have suggested a correlation between immune-related thyroid dysfunction (irTD) and the superior efficacy of anti-programmed cell death protein-1…”
Get full text

Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia by Waseda, Yuko, Yasui, Masahide, Kurokawa, Kousuke, Chikazawa, Ryo, Takeda, Toshihiro, Mitsui, Miho, Sonoda, Tomoaki, Yamaguchi, Makiko, Watanabe, Satoshi, Takato, Hazuki, Ichikawa, Yukari, Umeda, Yukihiro, Anzai, Masaki, Ueda, Hiroshi, Kasahara, Kazuo, Ishizuka, Tamotsu

“…Background Drug-induced pneumonia (d-pneumonia) and bacterial pneumonia (b-pneumonia) are often difficult to differentiate; therefore, this study examined the…”
Get full text

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer by Sonoda, Tomoaki, Nishikawa, Shingo, Sakakibara, Rie, Saiki, Masafumi, Ariyasu, Ryo, Koyama, Junji, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

“…In non-small cell lung cancer (NSCLC) with an epidermal growth factor receptor (EGFR) mutation, 50%–65% of cases acquire resistance after treatment with…”
Get full text

Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer by Nakashima, Koki, Umeda, Yukihiro, Demura, Yoshiki, Yamaoka, Koji, Sonoda, Tomoaki, Tada, Toshihiko, Waseda, Yuko, Ishizuka, Tamotsu

“…The efficacy of cytotoxic chemo-therapy has been reported to improve after immune checkpoint inhibitor (ICI) administration. We previously conducted a…”
Get more information

Crystal structure of isocitrate dehydrogenase from Aeropyrum pernix by Jeong, Jong-Jin, Sonoda, Tomoaki, Fushinobu, Shinya, Shoun, Hirofumi, Wakagi, Takayoshi

Get full text

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer by Ogusu, Shinsuke, Harutani, Yuhei, Tozuka, Takehiro, Saito, Ryota, Koyama, Junji, Sakamoto, Hiroaki, Sonoda, Tomoaki, Tsuchiya-Kawano, Yuko, Oba, Tomohiro, Kudo, Keita, Gyotoku, Hiroshi, Nakatomi, Katsumi, Ariyasu, Ryo

“…Background Evidence for use of second-line immunosuppressants for immune-related adverse events (irAEs) is inadequate. Therefore, a multicenter analysis should…”
Get full text

Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1–49 %): TOPGAN2023-01 by Tanaka, Hisashi, Makiguchi, Tomonori, Tozuka, Takehiro, Kawashima, Yosuke, Oba, Tomohiro, Tsugitomi, Ryosuke, Koyama, Junji, Tambo, Yuichi, Ogusu, Shinsuke, Saiki, Masafumi, Gyotoku, Hiroshi, Hasegawa, Tsukasa, Miyauchi, Eisaku, Sonoda, Tomoaki, Saito, Ryota, Nakatomi, Katsumi, Sakatani, Toshio, Kudo, Keita, Tsuchiya-Kawano, Yuko, Nishio, Makoto

“…Immune checkpoint inhibitors (ICIs) plus chemotherapy is now a standard treatment for non-small cell lung cancer (NSCLC). Whether ICI plus chemotherapy…”
Get full text

Comparison of ICI plus chemotherapy or ipilimumab plus nivolumab based therapy for patients with NSCLC with TPS (1-49%): TOPGAN2023-01 by Tozuka, Takehiro, Tanaka, Hisashi, Makiguchi, Tomonori, Kawashima, Yosuke, Oba, Tomohiro, Tsugitomi, Ryosuke, Koyama, Junji, Tambo, Yuichi, Ogusu, Shinsuke, Saiki, Masafumi, Gyotoku, Hiroshi, Hasegawa, Tsukasa, Miyauchi, Eisaku, Sonoda, Tomoaki, Saito, Ryota, Nakatomi, Katsumi, Sakatani, Toshio, Kudo, Keita, Tsuchiya-Kawano, Yuko, Nishio, Makoto

“…8550 Background: Nowadays,immune checkpoint inhibitor (ICI) plus chemotherapy is a standard treatment for non-small cell lung cancer (NSCLC) without targetable…”
Get full text

Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy by Ariyasu, Ryo, Horiike, Atsushi, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

“…Adrenal insufficiency is one of the adverse events (AEs) associated with anti-programmed death-1 (PD1) therapy. Delaying diagnoses can lead to serious…”
Get full text

High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer by Ariyasu, Ryo, Nishikawa, Shingo, Uchibori, Ken, Oh-hara, Tomoko, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Inase, Naohiko, Kasahara, Kazuo, Nishio, Makoto, Katayama, Ryohei

“…•Osimertinib response varies among T790M-positive NSCLC patients.•The T790M ratio to EGFR activating mutation in tumor varies among NSCLC patients.•The T790M…”
Get full text

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017 by Takano, Natsuki, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Saiki, Masafumi, Kawashima, Yosuke, Oguri, Tomoyo, Hisakane, Kakeru, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Horiike, Atsushi, Gemma, Akihiko, Nishio, Makoto

“…•The survival of advanced non-small-cell lung cancer improved in last two decades.•The approval of new classes of drugs impacted on the survival…”
Get full text

P3-079The case of non-small cell lung cancer followed by lip lymphoproliferative disease after immunotherapy by Sonoda, Tomoaki, Waseda, Yuko, Iino, Shiro, Imamura, Yoshiaki, Takeuchi, Mai, Umeda, Yukihiro, Morikawa, Miwa, Anzai, Masaki, Ishizuka, Tamotsu

“…Abstract Case 74 y.o. male Chief Complaint Lower lip nodule Present History On July in XXXX, left hilar tumor was detected by chest computed tomography, and…”
Get full text

The case of non-small cell lung cancer followed by lip lymphoproliferative disease after immunotherapy by Sonoda, Tomoaki, Waseda, Yuko, Iino, Shiro, Imamura, Yoshiaki, Takeuchi, Mai, Umeda, Yukihiro, Morikawa, Miwa, Anzai, Masaki, Ishizuka, Tamotsu

Get full text